Access to Controlled Medications: Barriers, Measuring Adequacy of Consumption, and Current Developments

Access to controlled medications is problematic in many countries, in spite of the objectives of the international substance control conventions. The review describes barriers for accessing medications and how to assess the adequacy of opioid analgesic consumption globally. As current trends in cons...

Full description

Bibliographic Details
Main Author: Willem Scholten
Format: Article
Language:English
Published: LSE Press 2020-08-01
Series:Journal of Illicit Economies and Development
Subjects:
Online Access:https://jied.lse.ac.uk/articles/59
_version_ 1797961705231220736
author Willem Scholten
author_facet Willem Scholten
author_sort Willem Scholten
collection DOAJ
description Access to controlled medications is problematic in many countries, in spite of the objectives of the international substance control conventions. The review describes barriers for accessing medications and how to assess the adequacy of opioid analgesic consumption globally. As current trends in consumption, it discusses the lack of progress of improving access and the threat of the false narrative that people who suffer moderate to severe pain are the cause of an epidemic of opioid intoxications. Finally, it questions the feasibility of an approach which requires large numbers of anaesthesiologist for treating chronic pain, and wonders what the effect of the COVID-19 pandemic on accessibility to controlled medications will be.
first_indexed 2024-04-11T01:01:55Z
format Article
id doaj.art-51c47e3473cc4cf2bce66771681a4cb9
institution Directory Open Access Journal
issn 2516-7227
language English
last_indexed 2024-04-11T01:01:55Z
publishDate 2020-08-01
publisher LSE Press
record_format Article
series Journal of Illicit Economies and Development
spelling doaj.art-51c47e3473cc4cf2bce66771681a4cb92023-01-04T15:01:02ZengLSE PressJournal of Illicit Economies and Development2516-72272020-08-012110.31389/jied.5938Access to Controlled Medications: Barriers, Measuring Adequacy of Consumption, and Current DevelopmentsWillem Scholten0Willem Scholten ConsultancyAccess to controlled medications is problematic in many countries, in spite of the objectives of the international substance control conventions. The review describes barriers for accessing medications and how to assess the adequacy of opioid analgesic consumption globally. As current trends in consumption, it discusses the lack of progress of improving access and the threat of the false narrative that people who suffer moderate to severe pain are the cause of an epidemic of opioid intoxications. Finally, it questions the feasibility of an approach which requires large numbers of anaesthesiologist for treating chronic pain, and wonders what the effect of the COVID-19 pandemic on accessibility to controlled medications will be.https://jied.lse.ac.uk/articles/59analgesicsopioidspain managementhealth policyneeds assessment
spellingShingle Willem Scholten
Access to Controlled Medications: Barriers, Measuring Adequacy of Consumption, and Current Developments
Journal of Illicit Economies and Development
analgesics
opioids
pain management
health policy
needs assessment
title Access to Controlled Medications: Barriers, Measuring Adequacy of Consumption, and Current Developments
title_full Access to Controlled Medications: Barriers, Measuring Adequacy of Consumption, and Current Developments
title_fullStr Access to Controlled Medications: Barriers, Measuring Adequacy of Consumption, and Current Developments
title_full_unstemmed Access to Controlled Medications: Barriers, Measuring Adequacy of Consumption, and Current Developments
title_short Access to Controlled Medications: Barriers, Measuring Adequacy of Consumption, and Current Developments
title_sort access to controlled medications barriers measuring adequacy of consumption and current developments
topic analgesics
opioids
pain management
health policy
needs assessment
url https://jied.lse.ac.uk/articles/59
work_keys_str_mv AT willemscholten accesstocontrolledmedicationsbarriersmeasuringadequacyofconsumptionandcurrentdevelopments